Myotonic Dystrophy.
Hamel JI.
Continuum (Minneap Minn). 2022 Dec 1;28(6):1715-1734. doi: 10.1212/CON.0000000000001184.
Myotonic dystrophy.
Thornton CA.
Neurol Clin. 2014 Aug;32(3):705-19, viii. doi: 10.1016/j.ncl.2014.04.011. Epub 2014 Jun 6.
Myotonic dystrophy type 2: the 2020 update.
Meola G.
Acta Myol. 2020 Dec 1;39(4):222-234. doi: 10.36185/2532-1900-026. eCollection 2020 Dec.
Diagnosis and Management of Myotonic Dystrophy Type 1.
Hartman J, Patki T, Johnson NE.
JAMA. 2024 Apr 9;331(14):1227-1228. doi: 10.1001/jama.2024.2511.
Update on the clinical and therapeutic aspects of myotonic dystrophy type 1.
Takahashi MP.
Curr Opin Neurol. 2025 Oct 1;38(5):531-537. doi: 10.1097/WCO.0000000000001374. Epub 2025 May 16.
Myotonic dystrophy.
Jozefowicz RF, Griggs RC.
Neurol Clin. 1988 Aug;6(3):455-72.
Myotonic Dystrophy: From Molecular Pathogenesis to Therapeutics.
Timchenko L.
Int J Mol Sci. 2022 Oct 8;23(19):11954. doi: 10.3390/ijms231911954.
Myotonic dystrophy.
Morgenlander JC, Massey JM.
Semin Neurol. 1991 Sep;11(3):236-43. doi: 10.1055/s-2008-1041227.
[Myotonic dystrophy and primary care].
Domínguez-González C.
Semergen. 2020 Oct;46(7):439-440. doi: 10.1016/j.semerg.2020.09.001. Epub 2020 Oct 7.
Myotonic dystrophy: diagnosis, management and new therapies.
Turner C, Hilton-Jones D.
Curr Opin Neurol. 2014 Oct;27(5):599-606. doi: 10.1097/WCO.0000000000000128.
